Remiges Ventures, Inc. — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
NapaJen Pharma, Inc.Sep 2021SEC filingmedium confidence
Clinical-stage biopharmaceutical company developing oligonucleotide therapeutics using an immune cell-targeted delivery platform.
BiotechBurlingame, US
BoardWalter Olesiak(Executive Officer, Director)Taro Inaba(Director)
Board seatKazuhiko Nonomura· per SEC Form D · $2M raise · filed Sep 2021
Co-investorsMitsui Global Investment
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.